Last December, the FDA (Food and Drug Administration) took the medicament Celebrex off drug store shelves in request of a group of consumers. Recent studies showed that the arthritis drug may increase the risk of heart attacks and strokes.
The medication was approved by the FDA on December 31, 1998 with the purpose of treating rheumatoid arthritis and osteo-arthritis. Celebrex is a non-steroidal anti-inflammatory drug (NSAID) and it belongs to a class of medicaments commonly referred to as "Cox-2 inhibitor." As with some others inhibitors, Celebrex held a roaring success and medics and patients described it as the "super aspirin". In September 2001, the American Heart Association, the National Stroke Association and the Arthritis Foundation asked the manufacturer to test whether or not it increased the risk of heart attacks and strokes.
Even though cardiovascular illnesses are the side effects that people concern about the most, there were other side effects related to Celebrex that proved to be dangerous: gastric hemorrhaging, kidney problems, allergies, abdominal pains, nausea, weight problems, inflammation, skin problems and fatigue. All the testing spears showed that the benefits of this medicine were little compared to the risks associated. This is the reason why many people set lawsuits and compensation claims.
Many patients using Celebrex looked into legal actions with the supervision of specialized lawyers. Attorneys of the field anticipated a large number of claims and lawsuits and offered advice to patient and victim relatives in regards of filing for class action or individual Celebrex lawsuits.
As time went by the number of cases being filed increased dramatically and many firms offered specialized legal assistance from drug litigation professionals.